691 related articles for article (PubMed ID: 28378454)
1. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
[TBL] [Abstract][Full Text] [Related]
2. Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.
Rodrigues D; Pinto J; Araújo AM; Monteiro-Reis S; Jerónimo C; Henrique R; de Lourdes Bastos M; de Pinho PG; Carvalho M
Metabolomics; 2018 Apr; 14(5):62. PubMed ID: 30830384
[TBL] [Abstract][Full Text] [Related]
3. Development of a headspace-solid phase microextraction gas chromatography-high resolution mass spectrometry method for analyzing volatile organic compounds in urine: Application in breast cancer biomarker discovery.
Li X; Wen X; Luo Z; Tian Y; Qian C; Zhang J; Ling R; Duan Y
Clin Chim Acta; 2023 Feb; 540():117236. PubMed ID: 36716910
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.
Monteiro MS; Barros AS; Pinto J; Carvalho M; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Guedes de Pinho P
Sci Rep; 2016 Nov; 6():37275. PubMed ID: 27857216
[TBL] [Abstract][Full Text] [Related]
5. Urine metabolomics analysis for kidney cancer detection and biomarker discovery.
Kim K; Aronov P; Zakharkin SO; Anderson D; Perroud B; Thompson IM; Weiss RH
Mol Cell Proteomics; 2009 Mar; 8(3):558-70. PubMed ID: 19008263
[TBL] [Abstract][Full Text] [Related]
6. Analysis of volatile human urinary metabolome by solid-phase microextraction in combination with gas chromatography-mass spectrometry for biomarker discovery: application in a pilot study to discriminate patients with renal cell carcinoma.
Monteiro M; Carvalho M; Henrique R; Jerónimo C; Moreira N; de Lourdes Bastos M; de Pinho PG
Eur J Cancer; 2014 Jul; 50(11):1993-2002. PubMed ID: 24820933
[TBL] [Abstract][Full Text] [Related]
7. Urinary Volatile Organic Compounds as Potential Biomarkers in Idiopathic Membranous Nephropathy.
Wang M; Xie R; Jia X; Liu R
Med Princ Pract; 2017; 26(4):375-380. PubMed ID: 28633145
[TBL] [Abstract][Full Text] [Related]
8. [Urinary metabolomics study of renal cell carcinoma based on gas chromatography-mass spectrometry].
Zhang L; Li L; Kong H; Zeng F
Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):763-6. PubMed ID: 26018279
[TBL] [Abstract][Full Text] [Related]
9. Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry.
Silva CL; Passos M; Câmara JS
Br J Cancer; 2011 Dec; 105(12):1894-904. PubMed ID: 22085842
[TBL] [Abstract][Full Text] [Related]
10. Use of solid-phase microextraction coupled to gas chromatography-mass spectrometry for determination of urinary volatile organic compounds in autistic children compared with healthy controls.
Cozzolino R; De Magistris L; Saggese P; Stocchero M; Martignetti A; Di Stasio M; Malorni A; Marotta R; Boscaino F; Malorni L
Anal Bioanal Chem; 2014 Jul; 406(19):4649-62. PubMed ID: 24828982
[TBL] [Abstract][Full Text] [Related]
11. UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
Wang Z; Liu X; Liu X; Sun H; Guo Z; Zheng G; Zhang Y; Sun W
BMC Cancer; 2019 Dec; 19(1):1195. PubMed ID: 31805976
[TBL] [Abstract][Full Text] [Related]
12. Headspace SPME-GC-MS metabolomics analysis of urinary volatile organic compounds (VOCs).
Zhang S; Raftery D
Methods Mol Biol; 2014; 1198():265-72. PubMed ID: 25270935
[TBL] [Abstract][Full Text] [Related]
13. Urinary Volatile Organic Compounds for the Detection of Prostate Cancer.
Khalid T; Aggio R; White P; De Lacy Costello B; Persad R; Al-Kateb H; Jones P; Probert CS; Ratcliffe N
PLoS One; 2015; 10(11):e0143283. PubMed ID: 26599280
[TBL] [Abstract][Full Text] [Related]
14. The volatilome - investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC).
Opitz P; Herbarth O
J Otolaryngol Head Neck Surg; 2018 Jul; 47(1):42. PubMed ID: 29970175
[TBL] [Abstract][Full Text] [Related]
15. Application of Urinary Volatile Organic Compounds (VOCs) for the Diagnosis of Prostate Cancer.
Gao Q; Su X; Annabi MH; Schreiter BR; Prince T; Ackerman A; Morgas S; Mata V; Williams H; Lee WY
Clin Genitourin Cancer; 2019 Jun; 17(3):183-190. PubMed ID: 30853355
[TBL] [Abstract][Full Text] [Related]
16. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine.
Lima AR; Pinto J; Azevedo AI; Barros-Silva D; Jerónimo C; Henrique R; de Lourdes Bastos M; Guedes de Pinho P; Carvalho M
Br J Cancer; 2019 Nov; 121(10):857-868. PubMed ID: 31588123
[TBL] [Abstract][Full Text] [Related]
17. Volatilomics Reveals Potential Biomarkers for Identification of Renal Cell Carcinoma: An In Vitro Approach.
Amaro F; Pinto J; Rocha S; Araújo AM; Miranda-Gonçalves V; Jerónimo C; Henrique R; de Lourdes Bastos M; Carvalho M; de Pinho PG
Metabolites; 2020 Apr; 10(5):. PubMed ID: 32349455
[TBL] [Abstract][Full Text] [Related]
18. Urine volatile organic compounds as biomarkers for minimal change type nephrotic syndrome.
Liu D; Zhao N; Wang M; Pi X; Feng Y; Wang Y; Tong H; Zhu L; Wang C; Li E
Biochem Biophys Res Commun; 2018 Jan; 496(1):58-63. PubMed ID: 29291407
[TBL] [Abstract][Full Text] [Related]
19. Urinary Volatilomics Unveils a Candidate Biomarker Panel for Noninvasive Detection of Clear Cell Renal Cell Carcinoma.
Pinto J; Amaro F; Lima AR; Carvalho-Maia C; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes de Pinho P
J Proteome Res; 2021 Jun; 20(6):3068-3077. PubMed ID: 33797920
[TBL] [Abstract][Full Text] [Related]
20. GC × GC-MS-Based Volatile Profiling of Male Domestic Cat Urine and the Olfactory Abilities of Cats to Discriminate Temporal Changes and Individual Differences in Urine.
Suzuki C; Miyazaki T; Yamashita T; Miyazaki M
J Chem Ecol; 2019 Jul; 45(7):579-587. PubMed ID: 31256322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
